APA (7th ed.) Citation

B, D., M, H., M, d. R., A, B., & V, S. (2026). The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke. The pharmacogenomics journal, 26(3), . https://doi.org/10.1038/s41397-026-00421-5

Chicago Style (17th ed.) Citation

B, Deiman, Hermans M, de Rijk M, Bras A, and Scharnhorst V. "The Association of ABCB1, CYP2C19 and CYP2C9 Combined Activity with Clopidogrel Resistance in Patients with Recurrent Ischemic Stroke." The Pharmacogenomics Journal 26, no. 3 (2026). https://doi.org/10.1038/s41397-026-00421-5.

MLA (9th ed.) Citation

B, Deiman, et al. "The Association of ABCB1, CYP2C19 and CYP2C9 Combined Activity with Clopidogrel Resistance in Patients with Recurrent Ischemic Stroke." The Pharmacogenomics Journal, vol. 26, no. 3, 2026, https://doi.org/10.1038/s41397-026-00421-5.